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Methods
• Information about age, disease duration, ESR, CRP, ultrasound (US) and clinical
joint examination (CJE) were captured for every patient.
• The joints in the hand were scanned using the US machine, Logiq S8 (GE Medical
Systems Ultrasound and Primary Care Diagnostics, Wauwatosa, WI, USA). SH
grade was recorded based on results of an ultrasound scan conducted on both
hands looking at 22 joints (MCPs 1-5 and PIPs 1-5) and the intercarpal, radial,
ulnar aspects of the wrist too. On US, synovial hypertrophy (SH), Power Doppler
(PD) signal, number of osteophytes (OPs) and erosions were assessed.
• On CJE, tender joint count (TJC), swollen joint count (SJC) and pain scores
(VAS) were obtained.
Statistical analysis:
• Analysis conducted using IBM SPSS Statistics. Means and SD were compared
using Student’s T test. Medians and IQR were compared using Mann Whitney U
test.
• Evaluate inflammatory joint involvement of the hands in a real life cohort of
SLE and SS patients referred for US assessment of their hand joints in the
context of clinical symptoms of arthralgia and arthritis
• To review the ultrasound characteristics of patients in systemic sclerosis and
SLE
• Correlate US findings with clinical and laboratory markers, and disease
activity scores (musculoskeletal ESSDAI and BILAG).
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Figure 1: Active inflammatory ultrasound features:
Objectives
MCP longitudinal view – SH grade 2, PD grade 2 MCP longitudinal view – SH grade 3, PD grade 1
MCP transverse view – PD grade 2
Design
A retrospective, observational study was conducted in 41 patients (902 joints) 
diagnosed with SLE and SS. 
Results
Conclusions
• Ultrasound examination was proven superior to clinical examination and blood test results for optimising the management of hand arthralgia/arthritis associated with SLE and SS.
• Our study provides useful information on the pattern of joint changes in SLE as we showed that active joint inflammation was found in 27.8% of SLE patients while twice as many
already had erosions.
• Future research is needed to establish if the development of erosions could be prevented by early diagnosis and prompt treatment of inflammatory arthritis associated with SLE and
SS.
• There was no significant correlation between the total PD score and
musculoskeletal BILAG and ESSDAI scores.
• There was no significant correlation between the total Grey Scale
score with either BILAG or ESSDAI scores.
• More than one in two SLE patients had erosions, while more than
one in three SS patients had erosions.
• US assessment prompted treatment changes (including both
optimisation of immunosuppressive therapy or analgesia based on
the results of the scan) in up to 61% of SLE patients and in 35% of
SS patients, who would have otherwise not had their treatment
changed based on BILAG/ESSDAI scores alone.
SLE (n=18) SS (n=23)
Age (mean +/- SD) 45.7+/- 12 51.4 +/- 14 p=0.18
Gender (% females) 94.4 100 p=0.25
Disease     duration (months, 
mean +/- SD)
14.04+/-14.8 8.9+/-9.8 p=0.21
% of patients on steroids 44.4 4.3 p=0.002
% of patients on cDMARDs 88.9 52.2 p=0.012
% of patients on Rituximab 11.1 8.7 p=0.79
% ANA 77.8 34.8 p=0.006
%dsDNA 27.8 13 p= 0.23
% ENA 55.6 56.5 p = 0.95
CRP (mean +/- SD) 4.98 +/- 4.17 4.69 +/- 6.04 p= 0.87
ESR (mean +/- SD) 31.41 +/- 26.11 23.35 +/- 19.78 p= 0.27
SJC (mean +/- SD)
(swollen joint count)
3.29 +/- 4.29 2.24 +/- 6.11 p= 0.58
TJC (mean +/- SD)
(tender joint count)
7.69+/-7.96 6.20+/-7.68 p= 0.59
Power Doppler (PD) score
Mean +/- SD
1.35+/-2.7 0.52+/-1.68 P=0.24
% of patients with PD signal 27.8 21.7 P = 0.65
Erosions score (mean +/- SD) 2.71+/- 3.62 2+/- 5.01 P=0.6249
% of patients with erosions 55.6 34.8 P = 0.18
Correlation of total Grey scale score 
with BILAG (SLE) and ESSDAI (SS)
R = 0.41
p= 0.09
R = 0.084
p = 0.70
Correlation of PD score with BILAG 
(SLE) and ESSDAI (SS)
R = 0.36
p = 0.14
R = 0.32
p = 0.13
• There was no significant correlation
between the total PD score and
musculoskeletal BILAG and ESSDAI
scores.
• There was no significant correlation
between the total Grey Scale score with
either BILAG or ESSDAI scores.
• More than one in two SLE patients had
erosions, while more than one in three SS
patients had erosions.
• US assessment prompted treatment
changes (including both optimisation of
immunosuppressive therapy or analgesia
based on the results of the scan) in up to
61% of SLE patients and in 35% of SS
patients, who would have otherwise not
had their treatment changed based on
BILAG/ESSDAI scores alone.
